ecancer

Niraparib significantly improves outcomes for ovarian cancer patients

Dr Mansoor Raza Mirza - Rigshospitalet, Copenhagen University Hospital, Denmark

8 Oct 2016

miRNA screening for germ cell tumours

Dr Matthew Murray - University of Cambridge, Cambridge, UK

5 Oct 2016

Editor's Choice for August 2016

Prof Gordon McVie - Editor in Chief, ecancer

22 Aug 2016

Review of olaparib for ovarian cancer

Dr Michel Vulfovich - Memorial Cancer Institute, Hollywood, Florida, USA

25 Jul 2016

A global perspective on infections related to cancer

Dr Silvia Franceschi - IARC, Lyon, France

1 Jul 2016

Breast and cervical cancer rates influenced by HRT, not contraceptive pill

Prof Valerie Beral - University of Oxford, Oxford, UK

30 Jun 2016

Monitoring HPV vaccination program impact in Bhutan and Rwanda

Dr Gary Clifford - IARC, Lyon, France

30 Jun 2016

Screening and early detection of cervical cancer in Africa

Dr Lynette Denny - University of Cape Town, Cape Town, South Africa

30 Jun 2016

Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers

Prof Usha Menon - University College London, London, UK

6 Jun 2016

MyPathway guidance of targeted therapy based on molecular profiles

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA

6 Jun 2016

Update on olaparib in ovarian cancer

Prof Jonathan Ledermann - University College Hospital Medical School, London, UK

6 Jun 2016

Intraperitoneal chemotherapy slows ovarian cancer progression

Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada

4 Jun 2016

More from ecancer